Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy

J Neurol. 2023 Oct;270(10):4707-4712. doi: 10.1007/s00415-023-11933-6. Epub 2023 Aug 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Demyelinating Diseases* / chemically induced
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects
  • Neoplasms* / drug therapy

Substances

  • Immune Checkpoint Inhibitors